GB Sciences is a plant-based research and biopharmaceutical drug development company based in Baton Rouge, LA. They are dedicated to creating patented formulations of plant-inspired, minimum essential mixtures for use as prescription medications, with a focus on therapies for Parkinson's disease and COVID-related cytokine release syndrome.
Utilizing their PhAROS Drug Discovery Platform, which incorporates AI technology, GB Sciences aims to identify and predict the efficacy of combinations of novel active ingredients from plants. With a strong research and development pipeline, partnerships with world-class researchers and development partners, and a commitment to preserving the efficacy of plant-based medicines, GB Sciences is at the forefront of the next generation of plant-inspired medicine.
Generated from the website